COVID-19 e Cardiologia
-
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
-
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
-
Vademecum utilizzo mascherine: Come sfruttare al meglio le mascherine sul nostro territorio
-
The Obstacle Course of Reperfusion for STEMI in the COVID-19 Pandemics
-
ST-Segment Elevation in Patients with Covid-19 — A Case Series
-
Covid 19 Sinossi d’emergenza
-
RIUNIONE GiViTI COVID19 10.03.2020 – PAZIENTI INTENSIVI
-
SARS-CoV-2 Infection in Children
-
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
-
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
-
Potential Effects of Coronaviruses on the Cardiovascular System
-
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
-
GUIDA CLINICA COVID-19 PER CARDIOLOGI
-
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
-
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line
-
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
-
Creating the New Normal: The Clinician Response to Covid-19
-
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease
-
COVID-19: state of art at 30.03.2020
-
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel
-
COVID-19 Clinical Guidance For the Cardiovascular Care Team
-
Covid-19 — Navigating the Uncharted
-
Covid-19 — A Reminder to Reason
-
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement
-
COVID-19 Coronavirus Cosa fare se siete affetti da ipertensione arteriosa – I consigli della SIIA
-
Consulenza Cardiologica e COVID-19
-
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected.
-
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
-
Circulation: Cardiovascular Quality and Outcomes
-
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection inWuhan, China
-
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
-
THERAPEUTIC ALGORITHM FOR COVID 19
-
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
-
Angiotensin‑converting enzyme 2 (ACE2) as a SARS‑CoV‑2 receptor: molecular mechanisms and potential therapeutic target
-
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
-
ESC Guidance for the Diagnosis and Management of COVID
-
Guida ESC per la diagnosi e la gestione della malattia CV durante la pandemia COVID-19